BFC Planning’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$339K Buy
916
+141
+18% +$49.8K 0.01% 742
2026
Q2
$278K Buy
775
+50
+7% +$15.3K 0.01% 822
2026
Q1
$182K Sell
725
-151
-17% -$37.6K 0.01% 908
2025
Q4
$241K Buy
876
+76
+10% +$20.8K 0.01% 807
2025
Q3
$210K Sell
800
-94
-11% -$22.8K 0.02% 652
2025
Q2
$196K Buy
894
+15
+2% +$3.21K 0.02% 646
2025
Q1
$197K Buy
879
+282
+47% +$77.7K 0.02% 619
2024
Q4
$196K Buy
597
+101
+20% +$31.8K 0.02% 623
2024
Q3
$149K Buy
+496
New +$152K 0.01% 722

Other funds holding WST

BFC Planning's WST Position: Q3 2026 in Review

BFC Planning increased its West Pharmaceutical (WST) stake by 18% in Q3 2026, buying an estimated $49.8K and bringing the position to 916 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #742.

BFC Planning first reported a position in WST in Q3 2024 and has held it in 9 quarters since. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • BFC Planning held 916 shares of West Pharmaceutical worth $339K as of Q3 2026.
  • BFC Planning bought 141 West Pharmaceutical shares in Q3 2026, an estimated $49.8K.
  • West Pharmaceutical made up 0.01% of BFC Planning's portfolio in Q3 2026, its #742 holding.
  • BFC Planning first reported a position in West Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.